These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


311 related items for PubMed ID: 35577782

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice.
    Zhang SS, Tian YH, Jin SJ, Wang WC, Zhao JX, Si XM, Zhang L, Xu H, Jin JY.
    Psychopharmacology (Berl); 2019 Nov; 236(11):3301-3315. PubMed ID: 31197433
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M, Lv D, Liu X, Li S, Chen Y, Zhang Y, Wang Z, Wang C.
    Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
    [Abstract] [Full Text] [Related]

  • 25. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
    Jiang C, Lin WJ, Labonté B, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR.
    Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prelimbic neuronal nitric oxide synthase inhibition exerts antidepressant-like effects independently of BDNF signalling cascades.
    Pereira VS, Suavinha ACDR, Wegener G, Joca SRL.
    Acta Neuropsychiatr; 2019 Jun; 31(3):143-150. PubMed ID: 30890202
    [Abstract] [Full Text] [Related]

  • 28. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B, Zhang JC, Han M, Yao W, Yang C, Ren Q, Ma M, Chen QX, Hashimoto K.
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [Abstract] [Full Text] [Related]

  • 29. Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23.
    Deyama S, Shimoda K, Suzuki H, Ishikawa Y, Ishimura K, Fukuda H, Hitora-Imamura N, Ide S, Satoh M, Kaneda K, Shuto S, Minami M.
    Psychopharmacology (Berl); 2018 Jan; 235(1):329-336. PubMed ID: 29090333
    [Abstract] [Full Text] [Related]

  • 30. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects.
    Hare BD, Shinohara R, Liu RJ, Pothula S, DiLeone RJ, Duman RS.
    Nat Commun; 2019 Jan 15; 10(1):223. PubMed ID: 30644390
    [Abstract] [Full Text] [Related]

  • 31. [Resolvin E1 as a potential lead for the treatment of depression].
    Deyama S, Minami M, Kaneda K.
    Nihon Yakurigaku Zasshi; 2024 Jan 15; 159(4):210-213. PubMed ID: 38945902
    [Abstract] [Full Text] [Related]

  • 32. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
    Carreno FR, Donegan JJ, Boley AM, Shah A, DeGuzman M, Frazer A, Lodge DJ.
    Mol Psychiatry; 2016 Sep 15; 21(9):1298-308. PubMed ID: 26619811
    [Abstract] [Full Text] [Related]

  • 33. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Hashimoto K.
    Psychopharmacology (Berl); 2015 Dec 15; 232(23):4325-35. PubMed ID: 26337614
    [Abstract] [Full Text] [Related]

  • 34. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E.
    Neuropharmacology; 2012 Jan 15; 62(1):391-7. PubMed ID: 21867718
    [Abstract] [Full Text] [Related]

  • 35. Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions.
    Loan Nguyen TM, Guilloux JP, Defaix C, Mendez-David I, Etting I, Alvarez JC, McGowan JC, Highland JN, Zanos P, Lovett J, Moaddel R, Corruble E, David DJ, Gould TD, Denny CA, Gardier AM.
    Neuropharmacology; 2024 Nov 01; 258():110065. PubMed ID: 39004413
    [Abstract] [Full Text] [Related]

  • 36. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A, Sens J, Herchick S, Thelen C, Pitychoutis PM.
    Neuroscience; 2015 Apr 02; 290():49-60. PubMed ID: 25595985
    [Abstract] [Full Text] [Related]

  • 37. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H.
    Pharmacol Biochem Behav; 2021 Dec 02; 211():173289. PubMed ID: 34655652
    [Abstract] [Full Text] [Related]

  • 38. Decreased efficacy of the ketamine and scopolamine-induced sustained antidepressant-like effects in rats receiving metformin.
    Chuang HW, Wei IH, Li CT, Huang CC.
    Pharmacol Rep; 2022 Apr 02; 74(2):340-352. PubMed ID: 34850372
    [Abstract] [Full Text] [Related]

  • 39. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling.
    Qu Y, Shan J, Wang S, Chang L, Pu Y, Wang X, Tan Y, Yamamoto M, Hashimoto K.
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr 02; 271(3):439-446. PubMed ID: 33180200
    [Abstract] [Full Text] [Related]

  • 40. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH, Mendez-David I, Defaix C, Guiard BP, Tritschler L, David DJ, Gardier AM.
    Neuropharmacology; 2017 Jan 02; 112(Pt A):198-209. PubMed ID: 27211253
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.